[go: up one dir, main page]

IT1270976B - INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM - Google Patents

INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Info

Publication number
IT1270976B
IT1270976B ITMI931806A ITMI931806A IT1270976B IT 1270976 B IT1270976 B IT 1270976B IT MI931806 A ITMI931806 A IT MI931806A IT MI931806 A ITMI931806 A IT MI931806A IT 1270976 B IT1270976 B IT 1270976B
Authority
IT
Italy
Prior art keywords
acyl
cholesterol
contain
pharmaceutical compositions
therapeutic activities
Prior art date
Application number
ITMI931806A
Other languages
Italian (it)
Inventor
Massimiliano Palladino
Ermes Vandotti
Manuela Villa
Massimo Bani
Rita Bometti
Vincenzo Olgiati
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Priority to ITMI931806A priority Critical patent/IT1270976B/en
Publication of ITMI931806A0 publication Critical patent/ITMI931806A0/en
Priority to GB9415873A priority patent/GB2280675A/en
Priority to JP6204436A priority patent/JPH07149733A/en
Priority to DE4428025A priority patent/DE4428025A1/en
Publication of ITMI931806A1 publication Critical patent/ITMI931806A1/en
Application granted granted Critical
Publication of IT1270976B publication Critical patent/IT1270976B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITMI931806A 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM IT1270976B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI931806A IT1270976B (en) 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
GB9415873A GB2280675A (en) 1993-08-06 1994-08-05 ACAT-inhibiting imidazoles
JP6204436A JPH07149733A (en) 1993-08-06 1994-08-05 Inhibitor compound of therapeutically active acyl enzyme-A-cholesterol-O-acyl-transfruase, use thereof and pharmaceutical composition containing the same
DE4428025A DE4428025A1 (en) 1993-08-06 1994-08-08 Inhibitors of acyl-enzyme-A-cholesterol O-acyl-transferase with therapeutic activity, their use and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI931806A IT1270976B (en) 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Publications (3)

Publication Number Publication Date
ITMI931806A0 ITMI931806A0 (en) 1993-08-06
ITMI931806A1 ITMI931806A1 (en) 1995-02-06
IT1270976B true IT1270976B (en) 1997-05-26

Family

ID=11366803

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI931806A IT1270976B (en) 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Country Status (4)

Country Link
JP (1) JPH07149733A (en)
DE (1) DE4428025A1 (en)
GB (1) GB2280675A (en)
IT (1) IT1270976B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200201204T2 (en) * 1999-11-05 2002-08-21 Warner Lambert Company Prevention of plaque rupture with ACAT inhibitors.
CN100438872C (en) * 2003-08-29 2008-12-03 兴和株式会社 2-[4-[2-(benzimidazol-2-yl-thio)ethyl]piperazin-1-yl]-N-[2,4-bis(methylthio)-6-methyl -Pharmaceutical use of 3-pyridyl]acetamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248528B (en) * 1991-06-21 1995-01-19 Pierrel Spa AROMATIC ETHER AND THIOETHER (HETER) DERIVATIVES HAVING ANTI-HYPERLIPIDEMIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
GB2280675A (en) 1995-02-08
ITMI931806A0 (en) 1993-08-06
DE4428025A1 (en) 1995-02-09
GB9415873D0 (en) 1994-09-28
JPH07149733A (en) 1995-06-13
ITMI931806A1 (en) 1995-02-06

Similar Documents

Publication Publication Date Title
NO305537B1 (en) Pharmaceutical preparation containing a defined lipid system and use of the lipid system
FI945434L (en) 4-Marcaptoacetylamino/2/benzazepinone (3) derivatives and their use as enkephalinase inhibitors
AR027162A1 (en) COMPOUNDS OF 2-PHENYL-3-PHENOXYL-PHENYLTIO-BENZOTIOFEN, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL122345A0 (en) Benzamide derivatives their use as vasopressin antagonists processes for the preparation thereof and pharmaceutical compositions containing the same
CA2293382A1 (en) Piperazine derivatives and their use as anti-inflammatory agents
MA26553A1 (en) ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FI961418L (en) Azole derivative and pharmaceutical composition thereof
FI962952L (en) Delta 12,13-iso-taxol analogues, their antineoplastic use and pharmaceutical compositions containing them
IT1243342B (en) ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES
ITMI912237A0 (en) GENESERIN DERIVATIVES THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT1277025B1 (en) CLASS OF PHOSPHODIESTERIC OLIGONUCLEOTIDES WITH CYTOTOXIC ACTIVITY PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE
HUP0004644A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
ITRM910189A0 (en) AMINOACIL AND OLIGOPEPTIDE DERIVATIVES OF ALLOPURINOL WITH IMMUNOSTIMULANT ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT8948430A0 (en) TRIPEPTIDE COMPOUNDS AND THEIR PHARMACEUTICAL USE AS IMMUNO-MODULATORS
IT1297205B1 (en) PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN WITH IMPROVED ABSORPTION, THEIR PREPARATION AND THEIR USE
FI20001777L (en) Substituted triazole sulfate salt and pharmaceutical compositions thereof
FI960487L (en) Benzopyrans and pharmaceutical compositions containing them
FI943705L (en) Pharmaceutical compositions
ZA933426B (en) New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them
IT1270976B (en) INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IL114208A0 (en) Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors
FI940726L (en) Pharmaceutical compositions
IT1290003B1 (en) USE OF PIVAGABINA TO PREPARE PHARMACEUTICAL COMPOSITIONS
ITFI920134A0 (en) 7-NEOPERENTIL XANTHINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960830